APEXIAN PHARMACEUTICALS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2005-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.apexianpharma.com
A Study of APX3330 in Patients With Advanced Solid Tumors
- First Posted Date
- 2017-12-15
- Last Posted Date
- 2020-09-07
- Lead Sponsor
- Apexian Pharmaceuticals, Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT03375086
- Locations
- 🇺🇸
Indiana University Simon Cancer Center, Indianapolis, Indiana, United States
🇺🇸START Midwest, Grand Rapids, Michigan, United States
🇺🇸START San Antonio, San Antonio, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath